Doctors have used the up-and-coming gene therapy tool CRISPR in a human for the first time as part of an ongoing clinical trial to treat a genetic condition called Leber congenital amaurosis (LCA). LCA is an inherited eye disorder that affects the retina (the layer of tissue at the back of the eye that detects…

Read More